WOCKPHARMANSEWockhardt Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 25 Mar · 15:18 IST

Wockhardt Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.5%1-day move
₹1137.00
prior close
₹1199.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.8+4.5+3.3+11.4+11.6+12.1+18.7+23.3+26.0+44.7+72.8
Up moveDown movePending
AI summary

Wockhardt Limited has informed the stock exchanges that the trading window for dealing in its equity shares will be closed from 1st April, 2026 until 48 hours after the declaration of audited financial results for the financial year ending 31st March, 2026. This closure is pursuant to the company's internal Code of Conduct under SEBI's Insider Trading Regulations, 2015. The date of the board meeting to approve the audited financial results will be communicated separately. The filing was made by Rashmi Mamtura, Company Secretary, on 25th March, 2026.

Likely market impact

This is a routine regulatory compliance filing. Designated persons including directors, employees, and insiders are restricted from trading in Wockhardt shares during this period. It signals that audited FY26 results are approaching but has no direct impact on the stock price.